Welcome to the forefront of pharma
How the pharma industry is stepping up to Covid-19 for a brighter, healthier future
In case you missed them, check out our collections on collaborative chemistry, everyday chemistry, voices in chemistry, sustainability and health technology
Pharmaceutical impurities: Combatting pharma’s elusive threat
Small molecule manufacturer Toronto Research Chemicals helps drug formulators eliminate impurities in the development pipeline, ensuring safer products make it to market
Faster pharma: Catalytic innovation combats precious metals supply chain pain
Precious metal catalysts are key to pharma but subject to market forces that make reliance on supply a double-edged sword.
AI and digital simulation for better medicines, made faster
Revolutionising pharma with next-generation technology to optimise and accelerate drug production processes
The future is bright: protecting innovation during uncertain times
The annual Pharma Integrates event facilitates conversation and collaboration to drive future innovation and improve patient outcomes worldwide
A pharmacist’s prescription for chemistry
Hands-on experience should not be dismissed lightly
Positive trial sets stage for therapeutic use of MDMA in US
Hallucinogen-assisted psychiatric treatment heads to regulators, amid cost and other concerns
Tornado at Pfizer plant accentuates US drug shortage issues
Perennial problem will not be addressed without major reforms to drug market
The drug developers fighting the antibiotic resistance problem
Andy Extance talks to the researchers innovating across different drug classes in the hunt to develop new treatments
Resistant to change
Curbing industrial practices that drive antimicrobial resistance needs tighter regulation and enforcement
Pharma podcasts
Sofosbuvir
The hepatitis C drug that made waves when first launched – quicker to work and with fewer side effects than existing drugs, but it came with a hefty price tag
Source: © Shutterstock
